Back

Prognosis of hypertrophic cardiomyopathy in Japanese patients with an implantable cardioverter defibrillator -focus on apical hypertrophic cardiomyopathy

29 August 2022 (14:15 - 14:45)
Organised by:
Congress Presentation Part of: Arrhythmic risk stratification according to aetiology Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Miyo Nakano

Chiba University Graduate School of Medicine, Chiba (Japan)

4 More presentations in this session

Presentation thumbnail
Non-sustained ventricular arrhythmias at exercise ECG predict severe ventricular arrhythmias in arrhythmic mitral valve prolapse
Doctor C. Five (Drammen, NO)
Abstract Slides
Presentation thumbnail
Implantable defibrillator-detected heart failure status predicts ventricular tachyarrhythmias
Doctor P. Compagnucci (Ancona, IT)
Abstract Slides
Presentation thumbnail
Ultra-high-frequency ECG assessment of QRS fragmentation predicts sudden cardiac death risk in inherited arrhythmia syndromes
Doctor K. Saleh (London, GB)
Abstract Slides
Presentation thumbnail
Clinical factors affecting survival in patients with D-transposition of the great arteries after atrial switch repair: a meta-analysis.
Ms S. Nartowicz (Poznan, PL)
Abstract Slides

Access the full session

Session thumbnail
Arrhythmic risk stratification according to aetiology

The Event

Event poster

ESC Congress 2022

29 August 2022 14:15 CET
You may be interested in
thumbnail
Congress Session
Risk assessment and prevention of sudden cardiac death in cardiomyopathies
thumbnail
Congress Session
Gaps in risk stratification for patients with structural heart disease
thumbnail
Webinar
The role of cardiac magnetic resonance for patients with ventricular arrhythmias and the prevention of sudden cardiac death in light of the 2022 ESC Guidelines

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources